Cheng-xian Guo
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Corrigendum to "CSDE1 enhances genotoxic drug resistance in cancer by modulating RPA2 through the CSDE1-eIF3a regulatory complex" [Drug Resist. Updat. 81 (2025) 101249].
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: August 22, 2026
Population pharmacokinetic/pharmacodynamic model of LY06006 in Chinese healthy subjects and postmenopausal osteoporotic women.
Journal: British journal of clinical pharmacology
Published: March 13, 2025
CSDE1 enhances genotoxic drug resistance in cancer by modulating RPA2 through CSDE1-eIF3a regulatory complex.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: February 16, 2025
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Journal: Innovation (Cambridge (Mass.))
Published: July 11, 2024
Anoikis in cell fate, physiopathology, and therapeutic interventions.
Journal: MedComm
Published: March 28, 2024
Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude.
Journal: The EPMA journal
Published: March 22, 2021
First-in-human, phase I single-ascending-dose study of the safety, pharmacokinetics, and relative bioavailability of selatinib, a dual EGFR-ErbB2 inhibitor in healthy subjects.
Journal: Investigational new drugs
Published: May 06, 2020
Epidemiological and clinical features of pediatric COVID-19.
Journal: BMC medicine
Published: March 25, 2020
A New Way to Discover IRESs in Pathology or Stress Conditions? Harnessing Latest High-Throughput Technologies.
Journal: BioEssays : news and reviews in molecular, cellular and developmental biology
Published: October 02, 2019
Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis.
Journal: European journal of drug metabolism and pharmacokinetics
Published: June 30, 2019
Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose.
Journal: British journal of clinical pharmacology
Published: April 21, 2019
Last Updated: 09/26/2026